New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals with average risk for the disease reported finding no colorectal cancers three years after an initial negative multi-target stool DNA test. These results suggest that at least a three-year interval between screenings using this method is clinically appropriate.